Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 March 2020 | Story Ruan Bruwer | Photo Supplied
Nomsa Mathontsi
Nomsa Mathontsi has been training with the South African senior women’s football team since Monday (03/02).

Whether she takes to the field or not, being part of the senior national women’s soccer team is already an accomplishment, says Nomsa Mathontsi. 

The BAdmin student in Economic and Management Sciences has been chosen for the Banyana Banyana squad for the first time. They face Lesotho on Sunday, 8 March 2020 in an international friendly in Johannesburg. There could be two Kovsies on the field, as Mating Monokoane, another University of the Free State student, was selected for Lesotho’s team. Both of them are midfielders.

The 21-year-old Mathontsi, who has been part of the Kovsie football team since 2018, says it will be a dream come true for her to wear the national colours. “Even if I don't get to play, I will still be proud of myself for being able to take on the challenge of going to camp and giving myself a chance to show my talent.”

“We have been together since Monday, 2 March 2020 and it has been the best experience, especially the fact that football has put me in the high-performance centre (South African Football Association girls’ academy), and now I get an opportunity to be with Banyana for the first time.”

“I was shocked when I got the call, but excited to face the challenge because it's never easy to get a call-up to Banyana, you need to work for it,” she says.

According to Mathontsi, who grew up in Mamelodi, Pretoria, her first love was athletics, but that changed during the 2010 World Cup in South Africa.
“I was an athlete back in primary school and it just so happened that I was selected to play football, which I never really enjoyed. I also had the opportunity to be part of the 2010 FIFA World Cup ceremonies, where I developed a love for football.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept